The detection, in the tumour, of a loss of heterozygosity (LOH) affecting the wild-type TP53 allele will constitute a strong argument in favour of the causal role of the detected TP53 variant in tumour development and the reality of the mosaicism. The gene discussed is TP53; the disease is neoplasm.